Method for Knowledge Acquisition and Decision-Making Process Analysis in Clinical Decision Support System

Author(s):  
Qingshan Li ◽  
Jing Feng ◽  
Lu Wang ◽  
Hua Chu ◽  
He Yu
2019 ◽  
Vol 14 (2) ◽  
pp. 187-197
Author(s):  
Nur Raidah Rahim ◽  
Sharifalillah Nordin ◽  
Rosma Mohd Dom

  Clinical decision support system (CDSS) is promising in assisting physicians for improving decision-making process and facilitates healthcare services. In medicine, causality has become the main concern throughout healthcare and decision-making. Causality is necessary for understanding all structures ofscientific reasoning and for providing a coherent and sufficient explanation for any event. However, thereare lack of existing CDSS that provide causal reasoning for the presented outcomes or decisions. Theseare necessary for showing reliability of the outcomes, and helping the physicians in making properdecisions. In this study, an ontology-based CDSS model is developed based on several key concepts andfeatures of causality and graphical modeling techniques. For the evaluation process, the Pellet reasoneris used to evaluate the consistency of the developed ontology model. In addition, an evaluation toolknown as Ontology Pitfall Scanner is used for validating the ontology model through pitfalls detection.The developed ontology-based CDSS model has potentials to be applied in clinical practice and helpingthe physicians in decision-making process. Keywords: clinical decision support system, ontology, causality, causal reasoning, graphical modeling


2021 ◽  
Vol 37 (S1) ◽  
pp. 21-22
Author(s):  
Carla Fernandez-Barceló ◽  
Elena Calvo-Cidoncha ◽  
Laura Sampietro-Colom

IntroductionIn the past decade, health technology assessment (HTA) has narrowed its scope to the analysis of mainly clinical and economic benefits. However, twenty-first century technology challenges require the need for more holistic assessments to obtain accurate recommendations for decision-making, as it was in HTA's foundations. VALues In Doing Assessments of health TEchnologies (VALIDATE) methodology approaches complex technologies holistically to provide a deeper understanding of the problem through analysis of the heterogeneity of stakeholders’ views, allowing for more comprehensive HTAs. This study aimed to assess a pharmaceutical clinical decision support system (CDSS) using VALIDATE.MethodsA systematic review of the empirical evidence on CDSS was conducted according to PRISMA guidelines. PubMed, the Cochrane Library, and Web of Science databases were searched for literature published between 2000 and 2020. Additionally, a review of grey literature and semi-structured interviews with different hospital stakeholders (pharmacists, physicians, computer engineers, etc.) were conducted. Content analysis was used for data integration.ResultsPreliminary literature results indicated consensus regarding the effectiveness of CDSS. Nevertheless, when including multistakeholder views, CDSS appeared to not be fully accepted in clinical practice. The main reasons for this appeared to be alert fatigue and disruption of workflow. Preliminary results based on information from the literature were contrasted with stakeholder interview responses.ConclusionsIncorporation of facts and stakeholder values into the problem definition and scoping for a health technology is essential to properly conduct HTAs. The lack of an inclusive multistakeholder scoping can lead to inaccurate information, and in this particular case to suboptimal CDSS implementation concerning decision-making for the technology being evaluated.


Open Medicine ◽  
2007 ◽  
Vol 2 (2) ◽  
pp. 129-139 ◽  
Author(s):  
Chi-Chang Chang ◽  
Chuen-Sheng Cheng

AbstractIn clinical decision making, the event of primary interest is recurrent, so that for a given unit the event could be observed more than once during the study. In general, the successive times between failures of human physiological systems are not necessarily identically distributed. However, if any critical deterioration is detected, then the decision of when to take thei ntervention, given the costs of diagnosis and therapeutics, is of fundamental importance This paper develops a possible structural design of clinical decision support system (CDSS) by considering the sensitivity analysis as well as the optimal prior and posterior decisions for chronic diseases risk management. Indeed, Bayesian inference of a nonhomogeneous Poisson process with three different failure models (linear, exponential, and power law) were considered, and the effects of the scale factor and the aging rate of these models were investigated. In addition, we illustrate our method with an analysis of data from a trial of immunotherapy in the treatment of chronic granulomatous disease. The proposed structural design of CDSS facilitates the effective use of the computing capability of computers and provides a systematic way to integrate the expert’s opinions and the sampling information which will furnish decision makers with valuable support for quality clinical decision making.


2019 ◽  
Author(s):  
Tamara Müller ◽  
Pietro Lio’

AbstractNeurodegenerative diseases such as Alzheimer’s and Parkinson’s impact millions of people worldwide. Early diagnosis has proven to greatly increase the chances of slowing down the diseases’ progression. Correct diagnosis often relies on the analysis of large amounts of patient data, and thus lends itself well to support from machine learning algorithms, which are able to learn from past diagnosis and see clearly through the complex interactions of a patient’s symptoms. Unfortunately, many contemporary machine learning techniques fail to reveal details about how they reach their conclusions, a property considered fundamental when providing a diagnosis. This is one reason why we introduce our Personalisable Clinical Decision Support System PECLIDES that provides a clear insight into the decision making process on top of the diagnosis. Our algorithm enriches the fundamental work of Masheyekhi and Gras in data integration, personal medicine, usability, visualisation and interactivity.Our decision support system is an operation of translational medicine. It is based on random forests, is personalisable and allows a clear insight into the decision making process. A well-structured rule set is created and every rule of the decision making process can be observed by the user (physician). Furthermore, the user has an impact on the creation of the final rule set and the algorithm allows the comparison of different diseases as well as regional differences in the same disease1.


Author(s):  
Sarin Shrestha

Millions of people around the world have diabetes. It is the seventh leading cause of death in US. An advancement of technologies may serve as the backbone for controlling diseases. Computerizing healthcare is expected to be one of the powerful levers essential for significant transformation in the quality and cost of delivering healthcare. Data management and technology is essential for providing the ability to exchange data and information at the right place in the right time to the right people in the healthcare process, to enable informed decision-making, and to achieve better health outcomes. Clinical Decision Support System (CDSS) provides guidance specific to the patient, including importing/entering patient data into the CDSS application and providing relevant information like lists of possible diagnoses, drug interaction alerts, or preventive care reminders to the practitioner that assists in their decision-making. This chapter has focuses on the use of CDSS for diabetes prevention.


Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 1309-P
Author(s):  
JACQUELYN R. GIBBS ◽  
KIMBERLY BERGER ◽  
MERCEDES FALCIGLIA

Sign in / Sign up

Export Citation Format

Share Document